Lupin Pharmaceuticals

Kindler is an alumnus of Tufts University and Harvard Law School. Zulueta holds degrees in Economics from De La Salle University and an MBA from the University of Virginia.

Lupin launches fixed-dose triple drug combination to manage asthma

The product will help in the management of inadequately controlled asthma by improving lung function, providing better symptom control and reducing exacerbations.

Lupin rationalising product portfolio in US to overcome price erosion impact: CEO

With its planned product pipeline for complex generic medicines in the next two years, she said in the years to come the company hopes to have up to 40 per cent of its revenue coming from such medicines in the US market.

Lupin Ltd gets USFDA nod for generic psoriasis treatment solution

Pharmaceutical major Lupin Ltd gets USFDA nod for a generic psoriasis treatment solution.

Lupin up 1.6%, launches Duloxetine 40 mg DR capsules in US

It is the first and only generic Duloxetine formulation to become available in 40 mg dosage strength, Lupin says, adding it is the only generic manufacturer to offer all Duloxetine dosage strengths.

Aurobindo Pharma hits new high on USFDA nod for antibiotic

Shares of Aurobindo Pharma spiked 2.7 percent to hit a record high of Rs 1,386.90 on Wednesday on US FDA nod for antibiotic drug.

Lupin gains 1%, US arm launches generic for arthritis drug

The pharma major said its US subsidiary, Lupin Pharmaceuticals Inc has launched the authorised generic for GD Searle LLC‘s (a subsidiary of Pfizer Inc.) Celebrex capsules 50 mg, 100 mg, 200 mg and 400 mg strengths.

Lupin launches generic Diovan HCT tablets

Pharma major, Lupin Ltd., announced today that its subsidiary Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its Valsartan and Hydrochlorothiazide Tablets USP.

Buy Lupin Pharma, Finolex Ind, Hexaware Tech: Joshi

In CNBC-TV18's popular show Bull's Eye, Sharmila Joshi, Peerless Securities shares trading strategy of the day.

Lupin launches generic seasonale tablets

Lupin Ltd., announced today has received final approval for its Levonorgestrel and Ethinyl Estradiol Tablets, from the United States Food and Drugs Administration to market a generic version of Teva Branded Pharmaceuticals (Teva) Seasonale® Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP).

Lupin receives FDA approval for Kurvelo tablets

Lupin Ltd., announced today that its subsidiary Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its oral contraceptive Kurvelo® Tablets.

Lupin gets US FDA nod for generic Avapro tablets

Pharma major Lupin today said its subsidiary, Lupin Pharmaceuticals, has received approval for its Irbesartan tablets from US Food and Drugs Administration to market a generic version of Sanofi Aventis's Avapro tablets.

Lupin gets USFDA nod for generic Avapro tablets

Lupin Pharmaceuticals has received approval for its Irbesartan tablets, used for treating hypertension, from US Food and Drugs Administration (USFDA) to market a generic version of Sanofi Aventis's Avapro tablets.

Lupin gets USFDA approval for generic Lexapro tablets

Drug firm Lupin Ltd today said it has received American health regulator's approval to market Escitalopram tablets, used in treating depressive disorders, in the US market.

Lupin gets US FDA nod for oral contraceptive generic

Lupin's subsidiary Lupin Pharmaceuticals Inc has received US Food and Drug Administration approval to sell Norgestimate and Ethinyl Estradiol tablets in various strengths.

Lupin gets US FDA nod for a copy of anti-acne drug Solodyn

Lupin's subsidiary Lupin Pharmaceuticals Inc has received final approval from US Food and Drugs Administration [FDA] for its abbreviated new drug application [ANDA] to market its Minocycline hydrochloride extended-release tablets, a generic version of Medicis Pharmaceutical Corp's Solodyn.

Hold Lupin Pharma; target of Rs 520: Unicon Investment

Unicon Investment has recommended hold rating on Lupin Pharmaceuticals with a target price of Rs 520, in its November 12, 2011 research report.

CIMA creates tomorrow's agenda for sustainable biz success

The Chartered Institute of Management Accountants (CIMA) and the leading think-tank Tomorrow’s Company brought business leaders from across India together at an event in Mumbai to create jointly tomorrow’s agenda for sustainable business.

Lupin gets final US FDA nod for generic antiepileptic drug

Lupin’s subsidiary Lupin Pharmaceuticals has received final approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application to market a generic version of anti-epilepsy drug Levetiracetam extended release tablets.

Lupin gets tentative USFDA approval for Pregabalin capsules

Drug-maker Lupin today said it has received tentative approval from the US health regulator to market Pregabalin capsules, used in the treatment of chronic pain as a result from an injury to the nervous system, in the American market.